Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

SNSE/GILD stock hub

SNSE/GILD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSE/GILDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

145.4T

Santiago Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SNSE/GILD

In the news

Latest news · SNSE/GILD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E17

P25 n/aP50 n/aP75 n/a

ROE43.4

P25 n/aP50 n/aP75 n/a

ROIC27.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE/GILD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	CL
Employees	17,000
Employees Change	-400%
Employees Change Percent	-2.22
Enterprise value	$155.4T
Exchange	Santiago Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$145.4T
Price	$110
Price currency	USD
Rev Per Employee	1,626,366,790.59x
Sic	2836
Symbol	snse/GILD
Website	https://www.gilead.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.89%
EV Earnings	18.14x
EV/EBIT	14.55x
EV/EBITDA	11.7x
EV/FCF	16.34x
EV/Sales	5.86x
FCF yield	6.54%
P/B ratio	6.67x
P/E ratio	16.96x
P/S ratio	5.26x
PE Ratio10 Y	73.41x
PE Ratio3 Y	123.96x
PE Ratio5 Y	81.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.3%
EBITDA Margin	49.56%
FCF margin	34.4%
Gross margin	79.37%
Gross Profit	$21.9T
Gross Profit Growth	4.91%
Gross Profit Growth Q	7.57%
Gross Profit Growth3 Y	3.3%
Gross Profit Growth5 Y	1.9%
Net Income	$8.6T
Net Income Growth	54.5%
Net Income Growth Q	53.69%
Net Income Growth3 Y	18.18%
Net Income Growth5 Y	98.24%
Pretax Margin	36.07%
Profit Margin	30.99%
Profit Per Employee	$504.1M
ROA	13.29
Roa5y	10.85
ROCE	25.61
ROE	43.36
Roe5y	24.33
ROIC	27.7
Roic5y	21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.07%
Cagr1y	26.95%
Cagr3y	23.67%
Cagr5y	15.64%
Div CAGR10	9.78%
Div CAGR3	5.23%
Div CAGR5	7.49%
EPS Growth	55.43
EPS Growth Q	54.81
EPS Growth3 Y	18.49
EPS Growth5 Y	98.31
FCF Growth	3.92%
FCF Growth Q	46.82%
FCF Growth3 Y	6.85%
FCF Growth5 Y	3.3%
OCF Growth	4.25%
OCF Growth Q	44.79%
OCF Growth10 Y	-5.37%
OCF Growth3 Y	6.38%
OCF Growth5 Y	2.95%
Revenue Growth	3.48x
Revenue Growth Q	4.4x
Revenue Growth3 Y	3.21x
Revenue Growth5 Y	3.07x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.53
Assets	$52.3T
Cash	$9.1T
Current Assets	$16.6T
Current Liabilities	$8.4T
Debt	$20.6T
Debt EBITDA	$1.49
Debt Equity	$0.95
Debt FCF	$2.17
Equity	$21.8T
Interest Coverage	11.94
Liabilities	$30.5T
Long Term Assets	$35.7T
Long Term Liabilities	$22.1T
Net Cash	$-10.6T
Net Cash By Market Cap	$-7.28
Net Debt EBITDA	$0.77
Net Debt Equity	$0.49
Net Debt FCF	$1.11
Tangible Book Value	$-1.1T
Tangible Book Value Per Share	$-884

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.97
Inventory Turnover	3.34
Net Working Capital	$614.6B
Quick ratio	1.54
Working Capital	$8.5T
Working Capital Turnover	$4,030

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.34%
Dividend Growth	1.41%
Dividend Growth Years	2%
Dividend per share	$2,965
Dividend Years	12
Dividend Yield	2,684.88%
Ex Div Date	2026-03-13
Last Dividend	$752
Payout Frequency	Quarterly
Payout Ratio	43.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	80.33%
1Y total return	26.93%
200-day SMA	110.4
3Y total return	89.19%
50-day SMA	110.4
50-day SMA vs 200-day SMA	50under200
5Y total return	106.8%
All Time High	115.9
All Time High Change	-4.72%
All Time High Date	2025-09-09
All Time Low	56.95
All Time Low Change	93.91%
All Time Low Date	2020-12-29
ATR	0
High52	115.9
High52 Date	2025-09-09
High52ch	-4.72%
Low52	89.71
Low52 Date	2025-06-13
Low52ch	23.1%
Ma50ch	0%
Price vs 200-day SMA	0%
RSI	100
RSI Monthly	98.31
RSI Weekly	100
Sharpe ratio	0.96x
Total Return	2,685.22%
Tr YTD	0.75
Tr3m	0.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$11.1T
Operating Income Growth	9.44
Operating Income Growth Q	6.55
Operating Income Growth3 Y	5.45
Operating Income Growth5 Y	0.53
Operating margin	40.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,239,252,307%
Net Borrowing	-2,488,481,680,000
Shares Insiders	0.1%
Shares Institutions	88.48%
Shares Qo Q	0.08%
Shares Yo Y	-0.34%
Short Ratio	3.53

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$8.7T
Average Volume	0x
Bv Per Share	17,603.9
CAPEX	$-535.6B
Ch10y	24.37
Ch1y	23.1
Ch3y	68.47
Ch5y	68.47
Change	0%
Close	110.4
Depreciation Amortization	2,453,721,370,000
Earnings Date	2026-05-07
EBIT	$11.1T
EBITDA	$13.7T
EPS	$6,836
F Score	8
FCF	$9.5T
FCF EV Yield	6.12x
Financing CF	-7,957,142,820,000
Fiscal Year End	December
Founded	1,987
Goodwill	7,410,185,060,000
Graham Number	49.23549
Graham Upside	-55.41
Income Tax	$1.4T
Investing CF	-2,424,892,320,000
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	$163
Lynch Upside	47.37
Ma150	110.4
Ma150ch	0%
Ma20	110.4
Ma20ch	0%
Net CF	-276,147,630,000
Next Earnings Date	2026-08-06
P FCF Ratio	15.28
P OCF Ratio	14.47
Payment Date	2026-03-30
Ppne	5,025,093,020,000
Price Date	2026-05-07
Price EBITDA	$10.61
Revenue	27,648,235,440,000x
SBC By Revenue	3.04x
Share Based Comp	839,600,370,000
Tax By Revenue	5.08x
Tax Rate	14.09%
Tr6m	1.47%
Z Score	4.51

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SNSE/GILD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2684.9%

$2965 annual per share

Payout ratio

+43.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+7.5%

2 consecutive years of growth

Total shareholder yield

+2685.2%

Next ex-dividend date: 2026-03-13

Performance

SNSE/GILD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE/GILD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.5%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE/GILD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

100.0

Above 70: short-term overbought

Price vs 200-day MA

0.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE/GILD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current snse/GILD stock rating?

snse/GILD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full snse/GILD analysis?

The full report lives at /stocks/snse/GILD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for snse/GILD?

The latest report frames snse/GILD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the snse/GILD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.